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Abstract
Objective The authors compared early-career psychiatrists’
selection of psychological treatments for patients with mild
to moderate major depressive disorder (MDD) in the US and
Japan.
Methods A total of 120 early-career psychiatrists from two
residency programs in the US and Japan participated in web-
based surveys. The psychiatrists selected first- and second-
line psychological treatments in response to two case vignettes
of patients with mild and moderate MDD.
Results Eighty-one psychiatrists (68 %) returned the sur-
veys, of whom 39 (48 %) were American and 42
(52 %) Japanese. In response to the mild MDD case,
more US psychiatrists selected high-intensity psycholog-
ical treatments (P<0.001), whereas more Japanese psy-
chiatrists selected low-intensity psychological treatments
(P<0.001). In both countries, more psychiatrists selected
psychological treatment than medication. In response to
the moderate MDD case, one third of the US psychia-
trists selected high-intensity psychological treatments
(P<0.001), whereas half of the Japanese psychiatrists
selected low-intensity psychological treatments (P=
0.010).
Conclusions Residency training, availability of psychological
treatments, and cultural beliefs may shape differences in treat-
ment selections, which in turn may impact the dissemination
and implementation of psychological treatment in clinical
practice across cultures.
Keywords Major depressive disorder . Psychotherapy .
Treatment selection . Residency . Culture
Although various psychological treatments have been shown
to be effective for the treatment of major depressive disorder
(MDD), few are readily available in clinical practice today,
even in high-income countries [1]. Although approximately
twice as many patients with MDD prefer psychological treat-
ments to medication [2], large-scale household surveys have
indicated that only a small fraction of patients with common
mental health disorders in the community are offered
evidence-based psychotherapy treatments [3]. Data from ap-
proximately 600 clinicians in independent practice indicate
that they primarily rely on past clinical experience rather than
empirical research to inform treatment decisions, illustrating a
wide and enduring research-practice gap in the dissemination
and implementation of psychological treatments [4].
According to McHugh and Barlow [1], the greatest chal-
lenge in disseminating and implementing evidence-based psy-
chological treatments is training clinicians to competently ad-
minister them. This training can be particularly difficult due to
the complex and nuanced nature of psychotherapy. Successful
training in psychological treatments involves both didactic
and competency training; the former requires information
transfer through written materials, lectures, and workshops,
and the latter requires acquisition of the skills necessary to
administer treatment with fidelity [1]. Because didactic train-
ing alone is insufficient to create sustainable changes in clin-
ical practice, recent attention has been focused on competency
training in the form of clinical supervision [5].
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In psychiatry, residency programs in the US and Japan
have similarly sought to increase psychological treatment
competency in early-career psychiatrists, including resi-
dents. Psychiatrists in the US are required to achieve com-
petency in low-intensity psychological treatment, such as
non-directive supportive therapy, as well as in high-
intensity psychological treatment, such as cognitive behav-
ior therapy (CBT) and psychodynamic psychotherapy [6].
According to a US survey of psychiatry residency training,
high-intensity psychological treatment training receives
more didactic and supervision time than low-intensity psy-
chological treatment training [7]. The Japanese Society of
Psychiatry and Neurology recommends the following tar-
gets for early-career psychiatrists in Japan: acquire basic
psychological skills (e.g., build positive relationships with
patients and their families), conduct low-intensity psycho-
logical treatment (e.g., supportive therapy), and understand
high-intensity psychological treatments (e.g., CBT, psy-
chodynamic psychotherapy) [8]. In comparison to the
US, greater emphasis is placed on the acquisition of basic
psychological skills to conduct low-intensity psychologi-
cal treatment; moreover, these targets are neither opera-
tionalized nor mandated across residency programs. The
quantity and quality of psychological treatment training
largely depends on the individual resident’s interests and
motivations to seek external resources [9]. New training
models to increase competency through clinical supervi-
sion are now being considered in Japan [10].
The purpose of this exploratory study was to compare
early-career psychiatrists in the US and Japan on their initial
selection of low- vs. high-intensity psychological treatment
for the management of mild to moderate MDD. Bower and
Gilbody [11] define treatment intensity as the amount of spe-
cialized therapist time required. In the present study, the low-
intensity psychological treatment included supportive therapy,
active monitoring, and active listening; the high-intensity psy-
chological treatment included CBT, interpersonal psychother-
apy, and psychodynamic psychotherapy. By examining early-
career psychiatrists’ decisions on which psychological treat-
ments to provide for patients with MDD, we aimed to better
understand the global issue of how to disseminate and imple-
ment psychological treatment in clinical practice across
cultures.
Methods
We evaluated a sample of 120 early-career psychiatrists who
have either completed residency within the past 6 years or are
current residents in two selected programs in Japan and the
US. Each program consists of 60 residents and operates within
large academic teaching hospitals in urban areas. The Japa-
nese residency program includes 2 years of general training
(postgraduate year (PGY) 1–2) and 4 years of psychiatric
training (PGY 3–6) following 6 years of medical school,
whereas the US residency program spans 4 years (PGY 1–4)
following 4 years of medical school. Both residency curricula
include rotations in outpatient and inpatient services in the
institutions’ teaching hospitals, other general hospitals, spe-
cialized clinics, and community mental health centers. In ad-
dition to treating patients, both groups participate in didactic
seminars, conferences, and research. Early-career psychia-
trists were selected because their treatment decisions may re-
flect their education and formal training more saliently than
would be the case for senior psychiatrists with years of clinical
experience. All participants had the standard workloads of
psychiatrists in their countries.
Between January and February of 2014, participants re-
ceived e-mail invitations to complete brief online surveys
about depression treatment. Participation was voluntary and
anonymous. Those interested in participating read an electron-
ic consent form detailing risks and benefits of the study. Those
who provided informed consent by checking the relevant box
on the webpage were able to initiate the survey. Participants
who completed the survey had the option of entering a raffle
with a 1 in 3 chance of receiving a $10 gift card. All study
procedures were approved by the residency directors of the
respective institutions and the KeioUniversity School ofMed-
icine Institutional Review Board.
A 10-min online survey developed for this study was self-
administered by participants to evaluate their demographic char-
acteristics, average daily outpatient workload, and selection of
the initial intervention forMDD treatment. The survey consisted
of two clinical case vignettes and 29 multiple-choice questions.
All measures were translated into Japanese and English by two
bilingual authors (AW, AN). The face validity and cultural ap-
propriateness of the case vignettes were confirmed by expert
clinicians (AN, MS, DM) with over 15 years of clinical experi-
ence treating patients with MDD in the US and Japan.
In the first two sections of the survey, the partici-
pants’ demographic characteristics (age, sex, year medi-
cal degree received) and information on previous and
current clinical experience (years of postgraduate train-
ing, clinical treatment settings) were collected. The av-
erage outpatient workload (daily patient volume, time
per patient) was also recorded.
In the main section, participants were asked to select which
initial treatment modality they would select for two individ-
uals with mild and moderate MDD, as described in the fol-
lowing case vignettes:
Case 1: Mild MDD
Ms. K, aged 24, presents with a chief complaint
of stress. The patient works as a legal assistant at a
law firm. She spends long hours working but fre-
quently makes minor clerical mistakes and feels bad
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for her coworkers. She is worried about making
mistakes at a large conference to be held next month
and has difficulty sleeping. She feels a bit better on
the weekends, when she does not have to work and
can see her friends from time to time.
Case 2: Moderate MDD
Mr. T, aged 29, married with a 6-month-old baby,
was laid off 2 months ago. Although he has been
searching for a new workplace, he has been unsuc-
cessful. His wife is very worried about their finances
and future. Family conversations are becoming less
frequent, and the atmosphere at home is tense, but
Mr. T does not feel he can ask his friends or parents
for help. He cannot see any way forward and feels
hopeless. He feels increasingly guilty and sorry for
his wife and daughter. The patient expresses some
suicidal ideation (“I wish I could fall asleep and
never wake up”) but has no specific suicide plans.
For each case vignette, participants selected an initial treat-
ment modality: low-intensity psychological treatment (i.e.,
supportive therapy, active monitoring, active listening), high-
intensity psychological treatment (i.e., CBT, interpersonal
psychotherapy, psychodynamic psychotherapy), pharmaco-
therapy, or others. Participants were subsequently asked
which second-line treatment they would choose if the patient
exhibited non-response after 4 weeks of initial pharmacother-
apy treatment. The second-line treatment options included:
psychotherapy, pharmacotherapy, or hospitalization.
Variables were tested for differences between the Japanese
and US psychiatrists using Student’s t test or the Mann-
Whitney U test for continuous variables and the χ2 test or
Fisher’s exact test for categorical variables, at a two-sided
P<0.05. We report the responses to the case vignettes as the
percentage of participants who selected each treatment modal-
ity. We used χ2 tests to determine the differences between the
Japanese and US psychiatrists’ treatment selections. Analyses
were done with SPSS 22.0 [12].
Results
We obtained responses from 39 (65 %) US psychiatrists and
42 (70 %) Japanese psychiatrists. The overall demographic
characteristics of the two groups did not differ significantly,
although the Japanese group included more men and had lon-
ger postgraduate training years. Fewer Japanese psychiatrists
had clinical training in child psychiatry services or community
health centers (Table 1).
We found significant differences between the average out-
patient workloads of the two groups. The Japanese psychia-
trists saw approximately 33 outpatients per day or 8 times the
number seen by their US counterparts (t=14.10, df=67,
P<0.001). The average length of a Japanese outpatient con-
sultation was 8 min, almost 30 min shorter than in the US
group (t=13.39, df=67, P<0.001) (Table 1).
For the initial treatment of patients with mild MDD, an over-
whelmingmajority of theUSpsychiatrists selected high-intensity
psychological treatment (US=30 (86%) vs. Japan=2 (6%),χ2=
45.13, P<0.001), whereas the majority of Japanese psychiatrists
selected low-intensity psychological treatment (Japan=22
(63 %) vs. US=2 (6 %), χ2=25.36, df=1, P<0.001) (Fig. 1).
For the initial psychological treatment of patients with
moderate MDD, about one third of the US psychiatrists se-
lected high-intensity psychological treatment, whereas no Jap-
anese psychiatrist selected this treatment (US=11 (31 %) vs.
Japan=0 (0 %), χ2=13.05, df=1, P<0.001). Instead, about
half of the Japanese psychiatrists selected low-intensity psy-
chological treatment, whereas less than a fifth of the US psy-
chiatrists chose this option (Japan=16 (46 %) vs. US=6
(17 %), χ2=6.63, df=1, P=0.010) (Fig. 1).
When asked about the second-line treatment selection after
4 weeks of non-response to pharmacotherapy, both US and
Japanese psychiatrists favored pharmacotherapy, and few se-
lected high-intensity psychological treatment for mild MDD
(Japan=3 (9 %) vs. US=7 (22 %)) and moderate MDD (Ja-
pan=1 (3 %) vs. US=5 (14 %)). We found no significant
differences between the two groups (Fig. 2).
Discussion
Overall in this study, early-career US psychiatrists favored
high-intensity psychological treatment, whereas Japanese psy-
chiatrists favored low-intensity psychological treatment as the
initial approach for patients with mild to moderate MDD. To
treat the patient with mild MDD described in the first vignette,
the US psychiatrists almost unanimously selected high-
intensity psychotherapy, as opposed to less than 10 % of the
Japanese psychiatrists. Most of the Japanese psychiatrists in-
stead selected low-intensity psychological treatment, whereas
less than 10 % of the US psychiatrists selected this option. In
response to the moderate MDD vignette, the difference was
less striking, but we found a statistically significant tendency
for the US psychiatrists to favor high-intensity psychological
treatment and for the Japanese to favor low-intensity
treatment.
The striking differences in the mean length and volume of
outpatient visits in the two groups highlight the issue of fea-
sibility. Japan has a universal health care system under which
almost all inhabitants have insurance and direct access to spe-
cialized medical services without having to be seen first by
primary care physicians [13]. Within this system, psychiatrists
provide first-line services for high volumes of patients with
various non-specific symptoms of mild to moderate severity
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who are normally treated by primary care physicians in other
countries. Psychiatrists with medical degrees, not clinical psy-
chologists or licensed clinical social workers, are the primary
providers of psychotherapy in Japan, and there is a shortage of
providers. With an average of 8 min per patient, the current
Japanese system does not allow enough time for selection of
or training for high-intensity psychological treatments, such as
CBT, which requires 50 min per session. Consequently, low-
intensity psychological treatment and pharmacotherapy be-
come the preferred, feasible options. More Japanese than US
psychiatrists selected medication to treat both mild and mod-
erate MDD. In Japan, Kasahara’s “minor psychotherapy,” a
type of supportive therapy for the initial treatment of depres-
sion requiring only 15 min per patient, is widely used [14].
This culture-specific psychological treatment includes
components of empathy, accepting attitude, therapeutic alli-
ance, psychoeducation, recommendations for rest, and phar-
macotherapy [15] and is recommended in the Japanese Soci-
ety of Mood Disorders guidelines as the initial treatment for
mild MDD [16], indicating its societal acceptance and
prevalence.
The distinct emphases on psychological treatment training
during residency in the US and Japan may explain the differ-
ence between the two groups. As stated earlier, the US resi-
dency programs require early-career psychiatrists to achieve
competency in supportive therapy, CBT, and psychodynamic
psychotherapy. The residents begin training with supportive
therapy and subsequently learn CBTand psychodynamic psy-
chotherapy with its unique theories, techniques, and goals for
treatment in practice [6]. Although the Japanese residency
Table 1 Demographic
characteristics of the Japanese and
American psychiatrists (n=81)
Variables Japanese (n=42) US (n=39) Analysis
Mean SD Mean SD t df P
Age (years) 34.0 5.2 32.5 4.7 1.34 73 0.09
Postgraduate years 6.9 2.2 3.3 2.6 6.38 73 <0.001
Outpatient workload
- Number of patients per day 32.7 12.1 4.4 2.4 14.10 67 <0.001
- Length of consultation per patient (min) 8.3 2.6 36.1 13.4 13.39 67 <0.001
N % N % χ2 df P



































































(b) Moderate MDD 
(a) Mild MDD Fig. 1 Selection of first-line
treatment modality for mild and
moderate MDD. aMild MDD.
The graph illustrates the
distribution of first-line treatment
selections for mild MDD between
Japanese (n=35) and US (n=35)
samples. bModerate MDD. The
graph illustrates the distribution
of first-line treatment selections
for moderate MDD between
Japanese (n=35) and US (n=35)
samples
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program follows a similar trajectory, it largely focuses on the
primary ability to conduct low-intensity psychological treat-
ment, such as non-directive supportive therapy [8]. Effective
doctor-patient communication is associated with patient satis-
faction, treatment adherence, and symptom improvement
[17]. As such, clinical methods such as therapeutic alliance,
clinical interviewing skills, and active listening are viewed as
important prerequisites in any approach to psychological treat-
ment and therefore emphasized in Japanese residency pro-
grams over supervised clinical experience in high-intensity
psychological treatments like CBT. Training in specific psy-
chological treatment models, such as CBT or psychodynamic
psychotherapy, is not a requirement for psychiatry residents in
Japan [9] and limited in availability, mostly left to the discre-
tion of individual psychiatrists who are strongly interested.
Furthermore, long-term psychotherapy treatment is often not
feasible in the Japanese residency curricula, where residents
rotate at several affiliated teaching hospitals and do not con-
sistently see the same patients. Of note, the Japanese sample
had a significantly higher number of postgraduate training
years completed and therefore may exhibit some knowledge
and skill drift from their original training in comparison to the
US sample.
Finally, the differences in training and treatment selections
must be considered in relation to the cultural frameworks sur-
rounding psychological treatment in the US and Japan. West-
ern psychological treatment approaches highlight the experi-
ence of emotional distress and how it is influenced by patterns
of thought and behavior [18], as exemplified by Beck’s cog-
nitive model [19]. In high-intensity psychological treatment
such as CBT, patients actively learn to change their
thought to improve their emotional state and behavior.
Moreover, CBT emphasizes a collaborative therapist-
client relationship and teaches patients to be their own
therapist. This emphasis may fit appropriately within the
individualistic Western culture, which values the autonomous
individual [20].
Eastern psychological treatment approaches, in contrast,
teach clients to accept emotions and thoughts as transitory
and not conducive to conscious control [18]. For example,
emotional and physical rest is an important component of both
the indigenous Morita therapy [21] and the above-mentioned
Kasahara’s minor psychotherapy. During the resting period,
clients accept the internal fluctuations of thoughts and feel-
ings, as in the concept of mindfulness. The doctor-patient
relationship in Japan, moreover, is often hierarchical [22].
There may be less sociocultural expectation of autonomous
choice and decision-making on the part of the patient during
treatment. In decisions regarding treatment, patients are more
likely to defer to clinicians, whom they consider to be experts.
This traditional doctor-patient relationship has been changing
since the late 1990s with the adoption of shared decision-
making models in the field of Japanese psychiatry, but the
change is still recent and gradual [22, 23]. In fact, the national
CBT program for treating Japanese patients with depression is
more directive and places greater emphasis on problem-
solving techniques within interpersonal contexts [24]. Given
these culturally influenced concepts of emotion and therapist-
client relationship, the relatively universal components of sup-























































(a) Mild MDD 
(b) Moderate MDD 
Fig. 2 Selection of second-line
treatment modality for mild and
moderate MDD. aMild MDD.
The graph illustrates the
distribution of second-line
treatment selections for mild
MDD between Japanese (n=34)
and US (n=32) samples. b
Moderate MDD. The graph
illustrates the distribution of
second-line treatment selections
for moderate MDD between
Japanese (n=35) and US (n=35)
samples
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partly explaining the Japanese tendency to prefer low-
intensity psychological treatment shown in our study results.
Considering the strong emphasis on biology and neurosci-
ence in psychiatry residency training and the time constraints
on psychiatrists, the relatively low selection of medication we
saw in this study in comparison to psychological treatment for
mild to moderate MDD was unexpected. The selections may
be shaped by prescribing guidelines, such as the Maudsley
prescribing guidelines [25] or the National Institute for Health
and Care Excellence guidelines [26], which do not recom-
mend pharmacotherapy as the first-choice treatment for mild
MDD. Moreover, Fournier and colleagues [27] have shown
that the benefits of antidepressants over placebos may be min-
imal or non-existent in patients with mild to moderate MDD.
The US residency program represented in our sample offers
supportive therapy, psychodynamic training, and CBT, in ad-
dition to neuroscience and psychopharmacology, which may
explain the relative inclination toward psychological treat-
ments that do not involve medication [28].
This study has several limitations. First, there is a selection
bias, and the relatively small sample of participants (n=81)
from two psychiatry residency programs may not represent all
early-career psychiatrists in the respective countries or world-
wide. The US residency program in our sample has a relative-
ly strong psychological treatment component, which could
produce a tendency toward selection of psychotherapy. Sec-
ond, our questionnaire was developed specifically for this
study and has not been validated. Third, case vignettes may
be interpreted differently from real-life clinical cases, and our
findings may not fully reflect actual treatment decisions that
psychiatrists make in clinical practice. Fourth, the treatment
choices offered to the psychiatrists in this study were broad
categories rather than specific psychotherapy models (e.g.,
CBT) or specific psychotherapeutic components (e.g., thera-
peutic alliance). Fifth, differences in the health insurance sys-
tems of the two countries—whichmay impact treatment avail-
ability and hence treatment selection—were not considered.
Despite these limitations, this preliminary analysis demon-
strates broad differences between the selections of high- and
low-intensity psychological treatments in the US and Japan.
Future studies will expand these broader categories into spe-
cific components of psychological treatment and compare the
treatment selections within larger samples of psychiatrists and
clinical psychologists in Western and Eastern countries.
In conclusion, preliminary results showed differences in
the rates of selection of high-intensity and low-intensity psy-
chological treatment for mild to moderate MDD made by
early-career psychiatrists in the US and Japan. It is often noted
that psychological treatment is relatively rare in Asia com-
pared to the West. This study provides a more nuanced ac-
count of the possible tendency toward low-intensity psycho-
logical treatment in Japan and high-intensity psychological
treatment in the US. Feasibility and the nature of training
may broadly impact the selection of psychological treatment;
moreover, deeply rooted cultural notions about psychological
treatments may also affect clinical decisions. In this era of
globalization, it is of great interest to continue exploring
how to effectively disseminate and implement psychotherapy
into clinical practice across multiple cultures.
Implication for Academic Leaders
• Residency training, availability of psychological treatment modalities,
and cultural customs and beliefs may shape treatment selection of
these modalities.
• Psychotherapy training for early-career psychiatrists in Japan must be
adapted to consider feasibility, including high patient volume and
limited patient time, for successful implementation of psychotherapy.
• Psychotherapy training for early-career psychiatrists in Japan may
place greater emphasis on directive, interpersonal approaches and
components of mindfulness to produce greater cultural fit. Early-
career psychiatrists in the US may also adopt these approaches for
patients from Japanese or Asian cultures.
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